Do somatostatin based therapies have any role in treating neuroendocrine tumors that are silent on octreotide scanning ?   

Possibly...there seems to be an association between the intensity of uptake and response to somatostatin analogs (SSAs) in patients with G2/G3 NETs. Almost all express somatostatin receptors (SSTRs) to some degree. The big question is how you assess for the presence of receptors. Octreoscans have lo...